Teresa Whalen is the CEO of CytoAgents, a startup focused on the development of solutions to combat persistent and potentially deadly strains of Influenza, COVID19, and other viruses.

 

Teresa’s career spans 20 years in the healthcare industry, including health technology executive, life sciences investor, and clinical pharmacist. She has brought multiple successful life-changing healthcare products to market.

 

She currently leads a team of clinical drug development experts and scientific advisory board members aiming to revolutionize treatment for respiratory illnesses and viral epidemics.

 

In this interview, Teresa and Aaron discuss the long process of FDA approval, how Teresa came to lead the company, and the dangers of a cytokine storm.

Sign up for a Weekly Email that will Expand Your Mind.

 

Teresa Whalen’s Challenge; Surround yourself with people who are smarter than you.

 

Connect with Teresa Whalen

Teresa's Linkedin

CytoAgents Website

 

If you liked this interview, check out episode 338 with Courtney Williamson where we discuss developing a medical device or episode 413 with Dr. Gordon Vanscoy where we discuss his pharmacy that collects drugs for treating rare diseases.

Text Me What You Think of This Episode 412-278-7680

Underwritten by Piper Creative

Piper Creative makes creating podcasts, vlogs, and videos easy. 

 

How? Click here and Learn more.

 

We work with Fortune 500s, medium-sized companies, and entrepreneurs.

 

Follow Piper as we grow

YouTube

Instagram

Subscribe on iTunes | Stitcher | Overcast | Spotify